We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $375M
1-Year Est. Return 131.24%
This Fund
S&P 500
This Quarter Est. Return
+63.68%
1 Year Est. Return
+131.24%
3 Year Est. Return
+400.69%
5 Year Est. Return
+687.84%
10 Year Est. Return
AUM
$375M
AUM Growth
+$167M
Cap. Flow
+$78.9M
Cap. Flow %
21.04%
Top 10 Hldgs %
41.06%
Holding
81
New
18
Increased
32
Reduced
22
Closed
6

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$13.6M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12.8M
3
TER icon
Teradyne
TER
+$10.8M
4
GLW icon
Corning
GLW
+$9.04M
5
BE icon
Bloom Energy
BE
+$7.64M

Sector Composition

Rank Sector Weight
1 Technology 41.44%
2 Miscellaneous 22.43%
3 Industrials 20.38%
4 Communication Services 5.93%
5 Energy 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
26
Lam Research
LRCX
$339B
$6.62M 1.77%
15,283
+2,885
+23% +$876K
FDHY icon
27
Fidelity High Yield Factor ETF
FDHY
$610M
$6.19M 1.65%
126,339
+56,262
+80% +$2.77M
MPC icon
28
Marathon Petroleum
MPC
$115B
$5.7M 1.52%
22,279
+61
+0.3% +$15K
FDRR icon
29
Fidelity Dividend ETF for Rising Rates
FDRR
$765M
$5.38M 1.43%
82,906
-996
-1% -$63.8K
META icon
30
Meta Platforms (Facebook)
META
$1.71T
$5.3M 1.41%
9,408
-2,288
-20% -$1.4M
ASML icon
31
ASML
ASML
$611B
$3.75M 1%
+1,884
New +$3M
AGX icon
32
Argan
AGX
$5.45B
$3.68M 0.98%
+4,603
New +$3.06M
XNTK icon
33
State Street SPDR NYSE Technology ETF
XNTK
$1.87B
$2.94M 0.78%
7,532
+91
+1% +$30.4K
QQQ icon
34
Invesco QQQ Trust
QQQ
$474B
$2.9M 0.77%
3,941
-138
-3% -$94.9K
MSFT icon
35
Microsoft
MSFT
$3.69T
$2.55M 0.68%
6,839
-621
-8% -$251K
HWM icon
36
Howmet Aerospace
HWM
$89.6B
$2.5M 0.67%
9,304
-15
-0.2% -$3.85K
PH icon
37
Parker-Hannifin
PH
$117B
$2.31M 0.62%
2,365
-2,178
-48% -$2M
SPY icon
38
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$1.91M 0.51%
2,558
+3
+0.1% +$2.17K
LLY icon
39
Eli Lilly
LLY
$1.01T
$1.72M 0.46%
1,436
-3,683
-72% -$3.76M
VTV icon
40
Vanguard Morningstar Value ETF
VTV
$190B
$1.71M 0.46%
7,851
+347
+5% +$72.5K
MPLX icon
41
MPLX
MPLX
$59.2B
$1.69M 0.45%
30,000
-5,000
-14% -$279K
AVEM icon
42
Avantis Emerging Markets Equity ETF
AVEM
$27.9B
$1.6M 0.43%
+16,620
New +$1.53M
EPD icon
43
Enterprise Products Partners
EPD
$83.8B
$1.48M 0.39%
40,250
SGOV icon
44
iShares 0-3 Month Treasury Bond ETF
SGOV
$109B
$1.43M 0.38%
14,239
+1,254
+10% +$126K
SITM icon
45
SiTime
SITM
$16.6B
$1.11M 0.3%
+1,485
New +$936K
GRNY
46
FundStrat Granny Shots US Large Cap ETF
GRNY
$4.37B
$1.1M 0.29%
39,674
+6,160
+18% +$164K
VOT icon
47
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.8B
$1.08M 0.29%
3,527
-184
-5% -$53.1K
VO icon
48
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$1.05M 0.28%
13,026
+4,134
+46% +$320K
PWR icon
49
Quanta Services
PWR
$92.2B
$945K 0.25%
1,313
+635
+94% +$434K
VYM icon
50
Vanguard High Dividend Yield ETF
VYM
$81.9B
$902K 0.24%
5,705
+374
+7% +$58.5K

Similar funds

Geneva Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Geneva Partners held 81 positions worth $375M, up 80% from $208M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Geneva Partners deployed $78.9M of net new capital in Q2 2026, opening 18 new positions and adding to 32 existing holdings. Its largest new stake was Marvell Technology: 68,048 shares worth $20.3M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $3.76M trimmed.

  • Geneva Partners's largest Q2 2026 buy was Marvell Technology: 68,048 shares worth $20.3M.
  • Geneva Partners added most to Dell in Q2 2026, an estimated $4.08M increase.
  • Geneva Partners's biggest Q2 2026 reduction was Eli Lilly, cutting an estimated $3.76M.
  • Geneva Partners fully exited Vanguard Health Care ETF in Q2 2026, selling an estimated $8.04M.
  • Geneva Partners's ten largest holdings make up 41% of its $375M portfolio in Q2 2026.
  • Geneva Partners opened 18 new positions and closed 6 in Q2 2026.
  • Geneva Partners's portfolio value rose 80% quarter-over-quarter to $375M.

Based on Geneva Partners's 13F filing for Q2 2026, filed 10 Aug 2026.